Image: AACC and Life Dx bring the latest advances in laboratory medicine to the Middle East region (Photo courtesy of AACC)
AACC Middle East, a two-day conference organized by the American Association for Clinical Chemistry (Washington, DC, USA) in collaboration with Life Dx (Abu Dhabi, UAE) will bring the latest results of laboratory medicine to the Middle East region and showcase diagnostic innovation. The conference will cover a range of current topics, from infectious diseases to big data and new prenatal technology, as well as core laboratory areas in sample transport, laboratory management and quality control. Each session will be presented by experts in AACC scientific leadership to bring the latest results in laboratory medicine and build new networks among attendees.
The conference, which will be held at the Grand Hyatt in Dubai, United Arab Emirates, from November 5 to 6, will present the latest scientific developments in all disciplines relevant to the field of laboratory medicine. Leaders in laboratory science and management from countries across the region are invited to participate, including the United Arab Emirates, Kuwait, Oman, Bahrain, Qatar, Saudi Arabia, Jordan, Egypt, Turkey, Lebanon, Cyprus and across the continent. Participants will include laboratory directors and managers, government officials and representatives of the diagnostic industry. AACC Middle East attendees will also have the opportunity to network with their colleagues and experts from the US and the Middle East to share knowledge about new developments in laboratory medicine. The conference is intended for doctors, laboratory supervisors, directors (and/or deputy directors), laboratory managers (supervisors and/or non-supervisors), medical technologists, pathologists, immunologists, fellows, residents, interns and other specialists. Health is interested in laboratory medicine.
AACC Middle East attendees will be able to discuss cutting-edge research and technology in laboratory medicine and include laboratory management strategies that improve workflow and support accurate and efficient testing to improve treatment decisions and patient outcomes. They will also be able to apply modern laboratory test methods, technologies and data-driven approaches in the pre-analytical, analytical and post-analytical phases of sample handling. Additionally, participants will be able to describe data analytics and machine learning applications and considerations in clinical laboratories, summarize advances in biomarkers and detection of neurological diseases, renal function assessment, preeclampsia and newborn screening, and demonstrate the value and role of laboratory medicine in treatment decisions and patient outcomes.